Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis

Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis

No therapies have been proven to increase survival after a hepatic encephalopathy (HE) episode. We hypothesize that two doses of albumin could improve 90-day survival rates after a HE episode. Methods: (1) A randomized double-blind, placebo-controlled trial (BETA) was conducted in 12 hospitals. The...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Meritxell Ventura-Cots, Macarena Simón-Talero, Maria Poca, Xavier Ariza, Helena Masnou, Jordi Sanchez, Elba Llop, Núria Cañete, Marta Martín-Llahí, Alberto Amador, Javier Martínez, Ana Clemente-Sanchez, Angela Puente, Maria Torrens, Edilmar Alvarado-Tapias, Laura Napoleone, Mireia Miquel-Planas, Alba Ardèvol, Meritxell Casas Rodrigo, Jose Luís Calleja, Cristina Solé, German Soriano, Joan Genescà
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
clinical trial
meta-analysis
albumin
hepatic encephalopathy
Medicine
R
Accès en ligne:https://doaj.org/article/dddca517500840e4ae7162cc143da209
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/dddca517500840e4ae7162cc143da209

Documents similaires